ReviewThe Journal of clinical and aesthetic dermatology2018
Hidradenitis Suppurativa: Causes, Features, and Current Treatments.
Review in The Journal of clinical and aesthetic dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.
- "Efficacy and safety of bimekizumab in moderate-to-severe hidradenitis suppurativa: A systematic review and meta-analysis of RCTs".Medicine · 2026Pooled it
- Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.The British journal of dermatology · 2025Pooled it
- Evaluating the effectiveness of integrating a clinical pharmacist into a hidradenitis suppurativa clinic within the specialty of dermatology.Skin health and disease · 2026Article
- Reducing non-attendance in hidradenitis suppurativa clinics: insights from a specialty service audit.Irish journal of medical science · 2026Article
- Surgical approaches in the management of hidradenitis suppurativa: Techniques, risks, and clinical outcomes.Dermatology online journal · 2026Review
- Atypical facial hidradenitis suppurativa complicated by periorbital cellulitis: Case report and literature review.SAGE open medical case reports · 2026Article
- Adjunctive Hyperbaric Oxygen Therapy in the Multimodal Management of Refractory Gluteal Hidradenitis Suppurativa: A Case Report.Case reports in surgery · 2026Article
- Metastatic Crohn's disease unmasked: from elusive skin clues to diagnosis and treatment - a comprehensive review.Przeglad gastroenterologiczny · 2026Review
- NOD2-mediated immune dysregulation linking hidradenitis suppurativa and Yao syndrome: Insights from 2 cases.JAAD case reports · 2025Article
- Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet.Current nutrition reports · 2025Review
- Impaired Molecular Mechanisms Contributing to Chronic Pain in Patients with Hidradenitis Suppurativa: Exploring Potential Biomarkers and Therapeutic Targets.International journal of molecular sciences · 2025Article
- Minimally invasive management of hidradenitis suppurativa using a 1470 nm diode laser: a step-by-step description of our technique.BMC surgery · 2025Article
- Guselkumab In A Subset Of Multifailure Patients With Hidradenitis Suppurativa: Real-Word Evidence from Federico II.Clinical, cosmetic and investigational dermatology · 2025Article
- Assessment of knowledge of primary healthcare physicians in the western region of Saudi Arabia about Hidradenitis Suppurativa.Frontiers in medicine · 2025Article
- Antimicrobial and immunomodulatory activity of natural bioactive compounds - anFrontiers in immunology · 2025Article
- Comprehensive Codified Algorithms to Identify the Underestimated Burden of Hidradenitis Suppurativa in the United States.Dermatology and therapy · 2024Article
- Association between Inflammatory Markers and Psychometric Scores in Patients with Hidradenitis Suppurativa.Journal of clinical medicine · 2024Article
- Comprehensive Catalog of Variants Potentially Associated with Hidradenitis Suppurativa, Including Newly Identified Variants from a Cohort of 100 Patients.International journal of molecular sciences · 2024Article
- Factors Affecting Wound Healing after the Wide Surgical Excision of Hidradenitis Suppurativa Lesions.Journal of clinical medicine · 2024Article
- A Novel 3D Printed Model of Infected Human Hair Follicles to Demonstrate Targeted Delivery of Nanoantibiotics.ACS biomaterials science & engineering · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hidradenitis suppurativa (HS), a relatively common and chronic inflammatory skin disorder. HS can have debilitating consequences if not diagnosed and treated appropriately. Clinically defined by recurrent, inflamed nodules in intertriginous regions (i.e., axillary, inguinal, and perianal areas), HS can cause intense pain and, in severe disease stages, lead to the formation of fistulas, sinus tracts, and extensive scarring. Postpubertal onset and female preponderance further characterize HS. Numerous pathogenic mechanisms have been proposed in HS, including immune dysregulation, genetics, smoking, and obesity; however, the exact etiology remains to be elucidated. The association of HS with inflammatory bowel disease, cardiovascular disease risk factors, and psychiatric disorders suggests HS is a systemic disease. HS significantly impairs quality of life in patients in excess versus other skin diseases. Unfortunately, experiences indicate long diagnostic delays, which in many cases might be due to disease unawareness among physicians. Increased knowledge of HS is therefore important in order to optimize disease management and ultimately improve the quality of life of patients.
Indexed as
Identifiers
30519375PMC6239161W2988925406What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.